Evidence map›Paper›PMID 21768606›Full record

ArticleToxicological sciences : an official journal of the Society of Toxicology2011

Atrazine and breast cancer: a framework assessment of the toxicological and epidemiological evidence.

James W Simpkins, James A Swenberg, Noel Weiss, David Brusick, J Charles Eldridge, James T Stevens, Robert J Handa, Russell C Hovey, Tony M Plant, Timothy P Pastoor and 1 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Toxicological sciences : an official journal of the Society of Toxicology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. PBPK-Based Probabilistic Risk Assessment for Total Chlorotriazines in Drinking Water.Toxicological sciences : an official journal of the Society of Toxicology · 2016
    Article
  12. Article
  13. Article
  14. Article
  15. Multigeneration reproduction and male developmental toxicity studies on atrazine in rats.Birth defects research. Part B, Developmental and reproductive toxicology · 2014
    Article
  16. Effect of Nrf2 on rat ovarian tissues against atrazine-induced anti-oxidative response.International journal of clinical and experimental pathology · 2014
    Article
  17. Impaired mitochondrial metabolism and mammary carcinogenesis.Journal of mammary gland biology and neoplasia · 2013
    Review
  18. Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 1 country.

James W SimpkinsDepartment of Pharmacology and Neurosciences, University of North Texas Health Science Center, Fort Worth, Texas 76107, USA.
James A Swenberg
Noel Weiss
David Brusick
J Charles Eldridge
James T Stevens
Robert J Handa
Russell C Hovey
Tony M Plant
Timothy P Pastoor
Charles B Breckenridge
Fred Hutch Cancer Center · USSyngenta (United States) · USWake Forest University · USMagee-Womens Research Institute · USUniversity of Arizona · USUniversity of California, Davis · USUniversity of North Carolina at Chapel Hill · US

Funding

STOCHASTIC ANALYSIS OF FLOW AND TRANSPORT PHENOMENAP42ES005948 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FRY, REBECCA · 1992 to 2017
$45.4M
UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Melissa A. Troester · 2001 to 2026
$36.3M
NIEHS NIH HHS P30 ES010126NIEHS NIH HHS P42 ES005948
6 · The paper itself

Abstract

The causal relationship between atrazine exposure and the occurrence of breast cancer in women was evaluated using the framework developed by Adami et al. (2011) wherein biological plausibility and epidemiological evidence were combined to conclude that a causal relationship between atrazine exposure and breast cancer is "unlikely". Carcinogenicity studies in female Sprague-Dawley (SD) but not Fischer-344 rats indicate that high doses of atrazine caused a decreased latency and an increased incidence of combined adenocarcinoma and fibroadenoma mammary tumors. There were no effects of atrazine on any other tumor type in male or female SD or Fischer-344 rats or in three strains of mice. Seven key events that precede tumor expression in female SD rats were identified. Atrazine induces mammary tumors in aging female SD rats by suppressing the luteinizing hormone surge, thereby supporting a state of persistent estrus and prolonged exposure to endogenous estrogen and prolactin. This endocrine mode of action has low biological plausibility for women because women who undergo reproductive senescence have low rather than elevated levels of estrogen and prolactin. Four alternative modes of action (genotoxicity, estrogenicity, upregulation of aromatase gene expression or delayed mammary gland development) were considered and none could account for the tumor response in SD rats. Epidemiological studies provide no support for a causal relationship between atrazine exposure and breast cancer. This conclusion is consistent with International Agency for Research on Cancer's classification of atrazine as "unclassifiable as to carcinogenicity" and the United States Environmental Protection Agency's classification of atrazine as "not likely to be carcinogenic."

Indexed as

AdenocarcinomaAnimalsAtrazineBreast NeoplasmsCarcinogensEstrusFemaleFibroadenomaHerbicidesHumansInfertilityRatsRats, Inbred F344Rats, Sprague-DawleyRisk AssessmentSpecies SpecificityAtrazineCarcinogensHerbicides

Identifiers

PMID21768606
PMCPMC3179673
OpenAlexW2152346617

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.